TELA Bio
TELA· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -60.9% in FY2025
Antony Koblish is the CEO of TELA Bio and was paid $2.0M in FY2025 (Dec), down 6%.
Pay$100 in the stock at the end of FY21 → $9
Executives3
See all- 1Antony KoblishChief Executive OfficerFY2025
- 2Roberto CucaChief Operating Officer, Chief Financial Officer and Corporate SecretaryFY2025
- 3Jeffrey BlizardPresidentFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allTELA Bio paid its 3 named executives $4.0M in total in FY2025 (Dec). CEO Antony Koblish was paid $2.0M of that.
| Name | |||
|---|---|---|---|
| Antony KoblishChief Executive Officer | |||
| Roberto CucaChief Operating Officer, Chief Financial Officer and Corporate Secretary | |||
| Jeffrey BlizardPresident | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for TELA Bio. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board4
See all- Kurt AzarbarzinDirector · 7 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
- Federica O’BrienDirector · 6 yr on the boardIndependentAudit (Chair)—Paid as an executive
- Betty Jo RocchioDirector · 0 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- William PlovanicDirector · 0 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 30, 2026 | FY2025 |
| Annual report | 10-K | Mar 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 17, 2025 | FY2024 |
| Annual report | 10-K | Mar 21, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 18, 2024 | FY2023 |
| Annual report | 10-K | Mar 22, 2024 | FY2023 |
